A Comparison of Demographics, Disease Activity, Disability, and Treatment Among Rheumatoid Arthritis Patients with and without Osteoporosis

被引:6
作者
Abdulkhaliq, Altaf [1 ]
Cheikh, Mohamed [2 ,3 ]
Almuntashri, Fahad [4 ]
Alzahrani, Haneen [4 ]
Nadwi, Huda [4 ]
Kadi, Eithar [4 ]
Abed, Mutasem [4 ]
Janaini, Murad [4 ]
Monjed, Alaa [4 ]
Janoudi, Nahed [2 ]
Almoallim, Hani [4 ,5 ]
机构
[1] Umm Al Qura Univ, Fac Med, Dept Clin Biochem, Mecca, Saudi Arabia
[2] Doctor Soliman Fakeeh Hosp, Internal Med Dept, Jeddah, Saudi Arabia
[3] Fakeeh Coll Med Sci, Dept Med, Jeddah, Saudi Arabia
[4] Umm Al Qura Univ Makkah, Fac Med, Dept Med, Mecca, Saudi Arabia
[5] Umm Al Qura Univ, Alzaidi Chair Res Rheumat Dis, Mecca, Saudi Arabia
来源
OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS | 2021年 / 13卷
关键词
rheumatoid arthritis; osteoporosis; disease activity; biologic; disease modifying antirheumatic drugs; effects; RA OP; BONE-MINERAL DENSITY; DOUBLE-BLIND; REMISSION; WOMEN; ONSET; MULTICENTER; PREVALENCE; DICKKOPF-1; FRACTURES; DENOSUMAB;
D O I
10.2147/OARRR.S318810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Osteoporosis (OP) is one of the most common comorbidities associated with rheumatoid arthritis (RA). Literatures reported that the risk for developing OP was strongly associated with duration and severity of RA. We aim to elaborate on the consequences of OP on disease activity and management plan in patients with RA. Patients and Methods: A retrospective cohort study recruited 408 patients, including those with RA alone and with RA plus OP. The RA disease activity in the patients was assessed using disease activity score in 28 joints (DAS28-CRP). A statistical analysis was performed to compare data between the two groups of patients and determine any significant risk factor associated with the development of OP in RA patients. Results: Of 408 patients who were included in this study, 353 patients (86.5%) had only RA, while 55 patients (13.5%) had RA with OP and showed significant difference (P = 0.04) concerning age categories. Patients diagnosed with RA and OP had RA duration longer than RA-only patients (independent t-test, P = 0.01). The two groups had almost similar disease activity at the three clinical visits, as well, had nearly similar disability at their first visit, whereas RA with OP patients had significant greater disability at their 2nd and 3rd visits (independent t-test, P = 0.001). Both groups were treated with the same biologic and non-biologic medication of similar frequency, although RA patients with OP received steroid more frequently than patients had RA only (61.7% vs. 41.7%, chi square test, P = 0.03). Conclusion: There was no significant difference in disease activity at both groups of patients. However, RA with OP group had longer duration of RA, were more frequently treated with steroids, and had greater disability. We recommend physicians focus on controlling RA disease activity, early screening for and treating of OP.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 40 条
[31]   MODIFIED DISEASE-ACTIVITY SCORES THAT INCLUDE 28-JOINT COUNTS - DEVELOPMENT AND VALIDATION IN A PROSPECTIVE LONGITUDINAL-STUDY OF PATIENTS WITH RHEUMATOID-ARTHRITIS [J].
PREVOO, MLL ;
VANTHOF, MA ;
KUPER, HH ;
VANLEEUWEN, MA ;
VANDEPUTTE, LBA ;
VANRIEL, PLCM .
ARTHRITIS AND RHEUMATISM, 1995, 38 (01) :44-48
[32]   Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis [J].
Richards, J. Steuart ;
Cannon, Grant W. ;
Hayden, Candace L. ;
Amdur, Richard L. ;
Lazaro, Deana ;
Mikuls, Ted R. ;
Reimold, Andreas M. ;
Caplan, Liron ;
Johnson, Dannette S. ;
Schwab, Pascale ;
Cherascu, Bogdan N. ;
Kerr, Gail S. .
ARTHRITIS CARE & RESEARCH, 2012, 64 (12) :1864-1870
[33]   Involvement of WNT/β-catenin Signaling in the Treatment of Osteoporosis [J].
Rossini, Maurizio ;
Gatti, Davide ;
Adami, Silvano .
CALCIFIED TISSUE INTERNATIONAL, 2013, 93 (02) :121-132
[34]   An epidemiological analysis of the incidence of osteoporosis and osteoporosis-related fractures among the Saudi Arabian population [J].
Sadat-Ali, Mir ;
Al-Habdan, Ibrahim M. ;
Al-Turki, Haifa A. ;
Azam, Mohammed Quamar .
ANNALS OF SAUDI MEDICINE, 2012, 32 (06) :637-641
[35]   From bone biology to clinical outcome: state of the art and future perspectives [J].
Schett, Georg ;
Saag, Kenneth G. ;
Bijlsma, Johannes W. J. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) :1415-1419
[36]  
Sinigaglia L, 2000, J RHEUMATOL, V27, P2582
[37]   Rheumatoid arthritis [J].
Smolen, Josef S. ;
Aletaha, Daniel ;
Barton, Anne ;
Burmester, Gerd R. ;
Emery, Paul ;
Firestein, Gary S. ;
Kavanaugh, Arthur ;
McInnes, Iain B. ;
Solomon, Daniel H. ;
Strand, Vibeke ;
Yamamoto, Kazuhiko .
NATURE REVIEWS DISEASE PRIMERS, 2018, 4
[38]   Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial [J].
Takeuchi, Tsutomu ;
Tanaka, Yoshiya ;
Soen, Satoshi ;
Yamanaka, Hisashi ;
Yoneda, Toshiyuki ;
Tanaka, Sakae ;
Nitta, Takaya ;
Okubo, Naoki ;
Genant, Harry K. ;
van der Heijde, Desiree .
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (07) :899-907
[39]   Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose-response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)-a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial [J].
Takeuchi, Tsutomu ;
Tanaka, Yoshiya ;
Ishiguro, Naoki ;
Yamanaka, Hisashi ;
Yoneda, Toshiyuki ;
Ohira, Takeshi ;
Okubo, Naoki ;
Genant, Harry K. ;
van der Heijde, Desiree .
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (06) :983-990
[40]  
Terpos E, 2011, CLIN EXP RHEUMATOL, V29, P921